Growth Metrics

Resmed (RMD) Other financing activities (2016 - 2021)

Resmed's Other financing activities history spans 13 years, with the latest figure at $16.1 million for Q4 2021.

  • For Q4 2021, Other financing activities rose 4.76% year-over-year to $16.1 million; the TTM value through Dec 2021 reached $162.9 million, up 10.22%, while the annual FY2021 figure was $63.9 million, 11.96% up from the prior year.
  • Other financing activities reached $16.1 million in Q4 2021 per RMD's latest filing, down from $17.3 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $113.9 million in Q2 2021 to a low of -$914000.0 in Q2 2018.
  • Average Other financing activities over 5 years is $22.8 million, with a median of $13.7 million recorded in 2019.
  • Peak YoY movement for Other financing activities: rose 4.32% in 2018, then soared 45727.68% in 2020.
  • A 5-year view of Other financing activities shows it stood at $12.0 million in 2017, then grew by 4.53% to $12.5 million in 2018, then grew by 12.09% to $14.1 million in 2019, then increased by 9.34% to $15.4 million in 2020, then increased by 4.76% to $16.1 million in 2021.
  • Per Business Quant, the three most recent readings for RMD's Other financing activities are $16.1 million (Q4 2021), $17.3 million (Q3 2021), and $113.9 million (Q2 2021).